ZKSCAN3 and prostate carcinoma: While the pro-invasive and microenvironmental remodeling mechanisms established by ZKSCAN3 in prostate cancer demonstrate its conserved function as a cancer driver, its unique mode of action in pancreatic cancer reveals the complexity of tissue-specific regulation.